Bayer shares fall as judge questions settlement deal
The issue involves contradictory scientific reports about whether the weedkiller Roundup is, in fact, carcinogenic
07 July 2020 - 13:24
Frankfurt — Bayer shares fell more than 6% on Tuesday after a US judge questioned part of the German company’s proposed settlement to deal with future claims relating to allegations that its widely used weedkiller Roundup caused cancer.
Last month, Bayer agreed to pay as much as $10.9bn to settle close to 100,000 US lawsuits related to Roundup. That included $1.25bn to support a separate class agreement to address potential future litigation. That part of the settlement requires court approval...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.